Home » Topics » Regulatory

Regulatory
RSS

Abbot's divalproex newly formulated for once-daily dosing

July 27, 2000

Topically applied GAG synthesis inhibitors useful for corneal haze

July 27, 2000

Synergism reported by Aventis for combination chemotherapies

July 27, 2000

SmithKline Beecham submits sNDA for Paxil for use in PTSD

July 25, 2000

Fibrate/statin combinations claimed in recent patent literature by Bayer

July 24, 2000

Neuroprotective effects described for SB-269970

July 24, 2000

U.K. launch announced for Zyban

July 24, 2000

First regulatory approval obtained for Migard

July 21, 2000

Zambon and Sheffield submit IND for MSI-cromolyn

July 21, 2000

DepoMed's Metformin GR gives positive multiple-dose phase I results

July 21, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...